Renascience (TSE:4889) 5-Year Yield-on-Cost %: 0.00 (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4889 Renascience Inc TSE:4889
51 GF Score
Price 円1,148.00
GF Value 円305.40
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Renascience 5-Year Yield-on-Cost %?

Renascience TSE:4889 -6.67% 51 5-Year Yield-on-Cost % is 0.00 as of Sep. 02, 2026. GuruFocus rates TSE:4889 with a GF Score™ of 51/100 and a GF Value™ of 円305.40 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 316 Medical Devices & Instruments companies, Renascience ranks worse than 316455.38% on this metric.

Renascience's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Renascience's 5-Year Yield-on-Cost % or its related term are showing as below:



TSE:4889's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.41
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Renascience  (TSE:4889) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Renascience 5-Year Yield-on-Cost % Related Terms


TSE:4889 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison

For the Medical Devices subindustry, Renascience's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renascience 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Renascience's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Renascience's 5-Year Yield-on-Cost % falls into.


TSE:4889
51GF Score
Renascience Inc TSE:4889
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Renascience 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Renascience is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Renascience (TSE:4889) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Renascience and its competitors. According to the industry distribution chart, Renascience ranks #999999 out of 316 companies in the Medical Devices & Instruments industry.
Is Renascience's 5-Year Yield-on-Cost % too high?
Renascience's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Renascience ranks #999999 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Renascience has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Renascience's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Renascience ranks #999999 out of 316 companies for 5-Year Yield-on-Cost %. This places Renascience in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.41, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Renascience and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Renascience's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Renascience stock overvalued right now?
Based on GuruFocus' analysis, Renascience (TSE:4889) is currently considered Significantly Overvalued. The stock's GF Value™ is 円305.40, compared to a current price of 円1,148.00 — trading 275.9% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Renascience's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Renascience (TSE:4889), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Renascience (TSE:4889) Overvalued in 2026?

Based on GuruFocus' analysis, Renascience stock appears to be overvalued. The current stock price of 円1,148.00 is trading 275.9% above its estimated GF Value™ of 円305.40. GuruFocus considers Renascience to be Significantly Overvalued.

Key valuation signals for TSE:4889:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: 円305.40 vs. price of 円1,148.00 (275.9% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the TSE:4889 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Renascience Business Description

Address 2-1 Seiryo-cho, Aoba-ku, Miyagi, Sendai, JPN, 103-0023
Renascience Inc is engaged in the Development and commercialization of pharmaceuticals, medical devices, pieces of software as a medical device (SaMD) utilizing AI, etc.
51GF Score

Get the complete analysis for TSE:4889

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,148.00
Price
円305.40
GF Value